中国药物评价
中國藥物評價
중국약물평개
Chinese Journal of Drug Evaluation
2015年
5期
266-272
,共7页
田金徽%葛龙%赵晔%张珺%苏小杰%刘爱萍%张俊华
田金徽%葛龍%趙曄%張珺%囌小傑%劉愛萍%張俊華
전금휘%갈룡%조엽%장군%소소걸%류애평%장준화
网状Meta分析%PRISMA扩展申明%报告质量
網狀Meta分析%PRISMA擴展申明%報告質量
망상Meta분석%PRISMA확전신명%보고질량
Network Meta-analysis%PRISMA extension statement%Reporting quality
网状Meta分析( network Meta-analysis,NMA)目前作为循证医学发展的二代方法学,越来越受到各国卫生技术评估组织的认可。然而,目前NMA的报告存在严重的问题。本文针对NMA的优先报告规范———PRISMA( preferred reporting items for systematic reviews and meta analysis)扩展申明发表在Annals of Internal Medicine上,现将PRISMA扩展申明予以介绍,为国内研究人员撰写和报告高质量的NMA提供借鉴和参考。
網狀Meta分析( network Meta-analysis,NMA)目前作為循證醫學髮展的二代方法學,越來越受到各國衛生技術評估組織的認可。然而,目前NMA的報告存在嚴重的問題。本文針對NMA的優先報告規範———PRISMA( preferred reporting items for systematic reviews and meta analysis)擴展申明髮錶在Annals of Internal Medicine上,現將PRISMA擴展申明予以介紹,為國內研究人員撰寫和報告高質量的NMA提供藉鑒和參攷。
망상Meta분석( network Meta-analysis,NMA)목전작위순증의학발전적이대방법학,월래월수도각국위생기술평고조직적인가。연이,목전NMA적보고존재엄중적문제。본문침대NMA적우선보고규범———PRISMA( preferred reporting items for systematic reviews and meta analysis)확전신명발표재Annals of Internal Medicine상,현장PRISMA확전신명여이개소,위국내연구인원찬사화보고고질량적NMA제공차감화삼고。
Network Meta-analysis, as the second generation methodological tool of evidence-based medicine, is popular currently for health technology assessment organization from different countries.However, there were serious reporting flaws for network meta-analysis.Recently, PRISMA extension statement for network meta-analysis was published in Annals of Internal Medicine.To im-prove the reporting quality of network meta-analysis, PRISMA extension statement for network meta-analysis will be introduced to domestic researchers.